2026 NPPES data Ophthalmology Physician NPI 1396855482 M.D.
Verify on CMS →

STEFAN KARAS, M.D.

Ophthalmology Physician in HONOLULU, Hawaii. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 260 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
55%
generic claims · 45% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
86.203/100
▲ 3 pts above national avg 83.1 · [object Object]

What the federal data shows

STEFAN KARAS, M.D. reported a CMS MIPS final score of 86.203/100 — above the 83.1 national average — and filed 1,101 Medicare Part D claims in 2023.

86.203/100
MIPS score · +3 vs avg
1K
Part D claims, 2023
55%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STEFAN KARAS, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

86 Top 48% higher than 52% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

STEFAN KARAS, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about STEFAN KARAS, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 08/30/2006

NPI 1396855482

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

1,101 22% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

86.203/100 3.1030000000000086% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Hawaii

How Ophthalmology Physician compares to other specialties among Hawaii providers

Hawaii providers

Ophthalmology Physician share within Hawaii

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Hawaii

Medicare quality performance — MIPS

STEFAN KARAS, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average

High performer (top quartile)
MIPS Final Score
86.203/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 86.203/100 vs national avg 83.1

0%100%National avg83%86.2%
MIPS final score (Ophthalmology Physician) — 86.203/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEFAN KARAS, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 888 S KING ST, HONOLULU, HI, 96813, with a listed phone of (808) 522-4000. NPI 1396855482 was issued on 08/30/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KARAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,101 prescription claims written by this provider, covering 260 Medicare beneficiaries and totaling roughly $153K in drug spend, split 45% brand-name and 55% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 86.203/100 for the 2023 performance year (Quality 80.286, Cost 73.7239), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

888 S KING ST
HONOLULU, HI 96813

Provider Details

NPI 1396855482
Specialty Ophthalmology Physician
Credentials M.D.
Gender Male
NPI Issued 08/30/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

86.203
Final Score
Avg: 83.1
80.286
Quality
73.7239
Cost
100
Promoting Interoperability

Reporting: Group practice

Brand vs generic prescribing mix · Above average

STEFAN KARAS, M.D. — brand share 45.0%
Specialty average (est.)

45% brand-name claims vs 55% generic, on 1,101 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,101
Total Claims
$153K
Total Drug Cost
260
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,211
Total Day Supply
64,264
Brand vs Generic
45% brand / 55% generic
Brand Drug Cost
$116K
Generic Drug Cost
$38K

Patient Demographics

Average Patient Age
78.9 years
Avg HCC Risk Score
1.32
Gender Split
47% female / 53% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What STEFAN KARAS, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
342
Timolol Maleate
197
Brimonidine Tartrate
55
Brinzolamide
50
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
46
Pilocarpine Hcl
43
Vyzulta
Latanoprostene Bunod
36
Alphagan P
Brimonidine Tartrate
32
Lumigan
Bimatoprost
24
Dorzolamide Hcl
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How STEFAN KARAS, M.D. fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

STEFAN KARAS, M.D.'s 1,101 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Hawaii

Other clinicians with the same primary specialty enrolled in Hawaii, drawn from the same CMS NPPES roster as KARAS.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEFAN KARAS, M.D.'s specialty?
STEFAN KARAS, M.D. specializes in Ophthalmology Physician and practices in HONOLULU, Hawaii. Credentials: M.D..
How much does STEFAN KARAS, M.D. prescribe under Medicare Part D?
In 2023, STEFAN KARAS, M.D. wrote 1,101 Medicare Part D claims totaling $153K in drug costs for 260 beneficiaries.
What is STEFAN KARAS, M.D.'s Medicare quality score?
STEFAN KARAS, M.D. has a CMS MIPS Final Score of 86.203/100 (Quality: 80.286, Cost: 73.7239). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is STEFAN KARAS, M.D. located?
STEFAN KARAS, M.D. is located at 888 S KING ST, HONOLULU, HI, 96813. Phone: (808) 522-4000.
What is STEFAN KARAS, M.D.'s NPI number?
STEFAN KARAS, M.D.'s National Provider Identifier (NPI) is 1396855482, issued on 08/30/2006.
Does STEFAN KARAS, M.D. prescribe more brand-name or generic drugs?
STEFAN KARAS, M.D.'s prescribing is 45% brand-name and 55% generic drugs by claim count, with $116K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does STEFAN KARAS, M.D. prescribe most often?
Based on 2023 Medicare Part D data, STEFAN KARAS, M.D.'s most frequently prescribed drugs include Latanoprost, Timolol Maleate, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEFAN KARAS, M.D. accept Medicare?
STEFAN KARAS, M.D. appears in CMS Medicare data with 1,101 Part D claims and 260 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEFAN KARAS, M.D.'s credentials?
STEFAN KARAS, M.D.'s NPI is 1396855482 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology